PMID: 11320682Apr 26, 2001Paper

Antipsychotic metabolic effects: weight gain, diabetes mellitus, and lipid abnormalities

Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie
R S McIntyreS H Kennedy

Abstract

To review published and nonpublished literature describing changes in weight, glucose homeostasis, and lipid milieu with antipsychotics. A Medline search was completed using the words weight gain, diabetes mellitus, cholesterol, triglycerides, risperidone, clozapine, olanzapine, quetiapine, ziprasidone, predictors, prolactin, obesity, and conventional antipsychotics. Publications, including original articles, review articles, letters to the editor, abstracts or posters presented at professional meetings in the last 4 years, and references from published articles, were collected. Manufacturers, including Eli Lilly Canada Inc, JanssenOrtho Inc, Pfizer Canada Inc, AstraZeneca Inc, and Novartis Pharmaceuticals, were contacted to retrieve additional medical information. The topic of antipsychotic-induced weight gain is understudied, and there are relatively few well-controlled studies. Weight gain as a side effect has been described with both conventional and atypical antipsychotics. Moreover, some atypical antipsychotics are associated with de novo diabetes mellitus and increased serum triglyceride levels. Predictors of weight gain may be age, baseline body mass index, appetite stimulation, previous antipsychotic exposure, and anti...Continue Reading

References

May 1, 1979·Acta Psychiatrica Scandinavica·D A Johnson, M Breen
Mar 1, 1977·The American Journal of Psychiatry·G Gardos, J O Cole
May 1, 1992·The American Journal of Psychiatry·J S LambertiS B Schwarzkopf
May 1, 1992·The American Journal of Psychiatry·A Martin
Jan 1, 1992·Neuroscience and Biobehavioral Reviews·G N Wade, J E Schneider
Oct 1, 1990·Pharmacology, Biochemistry, and Behavior·T BaptistaB G Hoebel
Jan 1, 1992·The American Journal of Psychiatry·R LeadbetterM Downs
Mar 1, 1991·Brain Research Bulletin·E MurziL Hernandez
Jul 1, 1989·The British Journal of Psychiatry : the Journal of Mental Science·J H Dowson
Aug 1, 1988·The British Journal of Psychiatry : the Journal of Mental Science·E GoodallT Silverstone
Aug 1, 1988·Pharmacology, Biochemistry, and Behavior·M A ParadaB G Hoebel
Oct 1, 1987·European Journal of Cancer & Clinical Oncology·D Y WangJ L Hayward
Sep 1, 1985·Acta Psychiatrica Scandinavica·A K Gopalaswamy, R Morgan
Sep 1, 1970·Clinical Pharmacology and Therapeutics·M L ClarkE A Serafetinides
Nov 1, 1970·Psychosomatics·J M Holden, U P Holden
Jan 1, 1995·Schizophrenia Bulletin·J M Stanton
Sep 14, 1995·The New England Journal of Medicine·J E MansonF E Speizer
Sep 1, 1994·Psychopharmacology·A E WalshP J Cowen
Jul 1, 1994·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·L E AdlerJ M Giffith
Sep 1, 1994·The American Journal of Psychiatry·A KamranL Dunn
Jan 1, 1994·The American Journal of Psychiatry·D A Charney, R C Russell
Nov 4, 1993·The New England Journal of Medicine·J I IsojärviV V Myllylä
May 1, 1996·The American Journal of Psychiatry·G A Peterson, S L Byrd
Jun 1, 1996·The American Journal of Psychiatry·J R BustilloA Breier
Mar 1, 1996·Acta Psychiatrica Scandinavica·A E KostakoğluN Güvener
Sep 1, 1996·American Journal of Health-system Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists·P Ghaeli, R L Dufresne
Feb 1, 1997·The Annals of Pharmacotherapy·W KorenH Gur
Mar 1, 1997·The Journal of Clinical Psychiatry·A P PopliG E Jaskiw
May 1, 1997·The American Journal of Psychiatry·C L Raison, H M Klein
Mar 10, 1998·Molecular Psychiatry·T BrömelJ Hebebrand
Jul 21, 1998·Journal of Affective Disorders·M A FryeR M Post
Nov 3, 1998·Biological Psychiatry·D A WirshingW C Wirshing
Dec 16, 1998·Journal of Child and Adolescent Psychopharmacology·D L KellyC M Ushchak
Dec 19, 1998·Journal of Affective Disorders·D Marcotte
Apr 6, 1999·Schizophrenia Research·R A Dickson, W M Glazer
Apr 30, 1999·The Journal of Clinical Psychiatry·D B AllisonL J Cheskin
Jun 9, 1999·The American Journal of Psychiatry·A Gordon, L H Price
Jun 16, 1999·Progress in Neuro-psychopharmacology & Biological Psychiatry·T BaptistaL Hernández

❮ Previous
Next ❯

Citations

Feb 7, 2002·Pharmacoepidemiology and Drug Safety
May 15, 2002·Journal of Clinical Psychopharmacology·Pál CzoborJeffrey A Lieberman
Jul 2, 2003·Journal of Clinical Psychopharmacology·Norman Sussman
Oct 2, 2003·The Annals of Pharmacotherapy·L Douglas RiedWilfred W Acholonu
Oct 21, 2003·Drugs & Aging·Yoram Barak, Dov Aizenberg
Feb 24, 2004·CNS Spectrums·Paul E Holtzheimer, John F Neumaier
Sep 17, 2005·Journal of Psychopharmacology·Valérie J Fedorowicz, Eric Fombonne
Dec 29, 2005·Journal of Child and Adolescent Psychopharmacology·Frank M TheisenHelmut Remschmidt
Jan 12, 2008·Journal of Psychiatric and Mental Health Nursing·M Jones, A Jones
Dec 25, 2008·Psychopharmacology·Steven M GrauerSharon Rosenzweig-Lipson
Dec 25, 2010·Pharmacoepidemiology and Drug Safety·Elaine H MorratoJohn W Newcomer
Sep 12, 2013·Clinical Psychopharmacology and Neuroscience : the Official Scientific Journal of the Korean College of Neuropsychopharmacology·You-Kyung KoJong-Il Lee
Nov 19, 2013·Clinical Drug Investigation·Alfonso Rodríguez-Martínez, Carlos Guzmán Quilo
Jul 10, 2014·Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie·Sakina J RizviSidney H Kennedy
Nov 19, 2015·Journal of Psychopharmacology·Ekramy ElmorsyMohammed Shoaib
Jan 8, 2018·Molecular Neurobiology·Vincenzo MondaAntonietta Messina
Oct 28, 2017·The Journal of Nervous and Mental Disease·Fernando CaravaggioRagy Girgis
May 17, 2018·Biometals : an International Journal on the Role of Metal Ions in Biology, Biochemistry, and Medicine·Natacha E PiloniSusana Puntarulo
Jul 21, 2020·The Cochrane Database of Systematic Reviews·Agnes TullyFionnuala Jordan
Jan 22, 2002·International Clinical Psychopharmacology·N MohrD J Stein
Sep 11, 2004·Journal of Psychopharmacology·Michael A WebberAnantha Shekhar
Jul 17, 2004·British Journal of Clinical Pharmacology·Kang SimChay H Tan
Sep 10, 2004·Journal of Clinical Psychopharmacology·Henry A Nasrallah, John W Newcomer
Jul 3, 2007·Social Psychiatry and Psychiatric Epidemiology·Carolyn HarleyWilliam Carson
Apr 2, 2009·The British Journal of Psychiatry : the Journal of Mental Science·Charles E Dean, Paul D Thuras
Jun 7, 2007·Current Opinion in Psychiatry·Roger S McIntyreSidney H Kennedy
Nov 30, 2011·International Journal of Psychiatry in Clinical Practice·Hans RittmannsbergerThomas Zaunmüller
Mar 31, 2009·Advances in Therapy·Ha T T NguyenRoger S McIntyre
Apr 27, 2012·European Psychiatry : the Journal of the Association of European Psychiatrists·E VietaF Kapczinski
Dec 1, 2014·Irish Journal of Psychological Medicine·A CarballedoP Dodd
Mar 27, 2003·Bipolar Disorders·Roger S McIntyreSidney H Kennedy

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Tropical Medicine & International Health : TM & IH
Jean MacqHaileyesus Getahun
Anesthesiology Clinics of North America
Caroline Thyes, Donat R Spahn
The American Journal of Occupational Therapy : Official Publication of the American Occupational Therapy Association
V E Radonsky
© 2021 Meta ULC. All rights reserved